Development of a fluorescence polarization based high-throughput assay to identify Casitas B-lineage lymphoma RING

Xingliang Xie1, Lin Sun, Ziyan Yuan Pessetto

  • 1Department of Pharmacy, Chengdu Medical College, Chengdu, Sichuan Province, China.

Plos One
|November 9, 2013
PubMed

Insights

Researchers developed a high-throughput fluorescence polarization assay to find small molecules regulating Casitas B-lineage Lymphoma (Cbl) protein interactions. Three compounds were identified that bind to the Cbl (RING) domain and disrupt Cbl-UbCH7 protein interactions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Casitas B-lineage Lymphoma (Cbl) proteins are E3 ubiquitin ligases crucial for signal transduction.
  • Studying protein-protein interactions (PPIs) involving Cbl proteins is vital for understanding cellular signaling.
  • Identifying small-molecule regulators of PPIs is challenging due to the nature of PPI interfaces.

Purpose of the Study:

  • To develop a high-throughput screening assay for identifying small-molecule regulators of Cbl (RING) domain interactions.
  • To measure binding affinities and inhibition constants for Cbl (RING) domain and its interacting partners.
  • To discover novel compounds that modulate Cbl (RING)-UbCH7 protein-protein interactions.

Main Methods:

  • Development of a competitive, homogeneous, high-throughput fluorescence polarization (FP) assay.
  • Optimization of assay conditions, comparing detergent-free and detergent-present systems.
  • Screening of a 10,000 natural compound library using the optimized FP assay.

Main Results:

  • The detergent-present system proved more effective for high-throughput screening.
  • Three compounds—methylprotodioscin, leonuride, and catalpol—were identified as potential binders to the Cbl (RING) domain.
  • These compounds demonstrated interference with the Cbl (RING)-UbCH7 protein-protein interaction.

Conclusions:

  • A robust FP assay was established for high-throughput screening of Cbl (RING) domain regulators.
  • Novel small molecules capable of modulating Cbl (RING)-UbCH7 interactions were discovered.
  • These findings provide a foundation for developing targeted therapeutics modulating Cbl-mediated signaling pathways.

Related Concept Videos